Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 22, 2007. The report details a specific corporate action regarding the repurchase of the company's own ordinary shares in accordance with shareholder authority granted at the Annual General Meeting on May 17, 2006.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the share repurchase price of 1,448.0571 pence per share.
Material Changes
- Share Repurchase: On February 22, 2007, the Company purchased 860,000 Ordinary shares of 25 pence each.
- Treasury Holdings: Following this transaction, the total number of shares held in Treasury increased to 255,887,678.
- Shares in Issue: The Company reported 5,752,734,147 shares in issue, excluding Treasury shares. This figure represents the total voting rights.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities and is made in conformity with the Transparency Directive's transitional provision 6.
Investor Verification Points
- Verify the total Treasury share count of 255,887,678 against subsequent filings.
- Confirm the total voting rights denominator of 5,752,734,147 shares for disclosure threshold calculations.
- Note that this filing is a notification of a specific transaction and does not contain periodic financial performance data.